PCFA
By Dr Wendy Winnall - PCFA Research Team
Treatments for advanced and metastatic prostate cancer are rapidly evolving. Recent trials have shown that adding chemotherapy to androgen deprivation therapy leads to improved survival rates. But the length of time that a patient survives is not all that's important to them. A new report has been published that examines the quality-of-life for men who start androgen deprivation therapy and chemotherapy at the same time.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
